Hangzhou Occupational Disease Prevention Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02341352
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

immune globulin (human) (1 trial)

probiotic (1 trial)

sodium fluoride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3